SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 on
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 13, 2003
INTERLEUKIN GENETICS, INC.
(Exact name of registrant as specified in its charter)
|
DELAWARE |
|
000-23413 |
|
94-3123681 |
|
(State or other |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
135 BEAVER STREET, WALTHAM, MA 02452 |
||||
|
(Address of principal executive offices) (Zip Code) |
||||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (781) 398-0700 |
||||
|
|
|
|
|
|
|
Not Applicable |
||||
|
(Former name or former address, if changed since last report) |
||||
The purpose of this amendment to our Current Report on Form 8-K filed with the Securities Exchange Commission on May 13, 2003, is to change the Item under which the press release reporting our results for the quarter ended March 31, 2003 appears.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
|
(c) |
Exhibit |
|
|
|
||
|
99.1 |
Press Release dated May 13, 2003 |
|
ITEM 9. REGULATION FD DISCLOSURE (INFORMATION FILED PURSUANT TO ITEM 12, “RESULTS OF OPERATIONS AND FINANCIAL CONDITION”).
On May 13, 2003, Interleukin Genetics, Inc. publicly disseminated a press release reporting its results for the quarter ended March 31, 2003. The information contained in the press release is incorporated herein by reference and filed as Exhibit 99.1 hereto.
This information filed under “Item 9. Regulation FD Disclosure” is intended to be filed under “Item 12. Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
INTERLEUKIN GENETICS, INC. |
|
||
|
|
|
|
(Registrant) |
|
||
|
Date: |
May 19, 2003 |
|
/s/ Fenel M. Eloi |
|
||
|
|
|
|
||||
|
|
|
Fenel M. Eloi, Chief Operating Officer, |
||||
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated May 13, 2003 |
4